4,3600
23-мая-25 13:45:00
15 мин. задержка
Акции
-0,0200
-0,46%
Сегодняшний диапазон
4,2400 - 4,4000
ISIN
N/A
Источник
NASDAQ
Verve Therapeutics Reports Preclinical Data Demonstrating Potent Editing of ANGPTL3 Gene Using Proprietary GalNAc-LNP Delivery Technology in Non-Human Primates
09 ноя 2021 03:30:00 Источник Nasdaq GlobeNewswire
Verve Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit
21 окт 2021 03:30:00 Источник Nasdaq GlobeNewswire